Rosiglitazone Decreases Plasma Levels of Osteoprotegerin in a Randomized Clinical Trial with Type 2 Diabetes Patients
2011 ◽
Vol 109
(6)
◽
pp. 481-485
◽
Keyword(s):
2018 ◽
Vol 12
(5)
◽
pp. 617-624
◽
Keyword(s):
2013 ◽
Vol 27
(5)
◽
pp. 501-507
◽
2012 ◽
Vol 45
(04)
◽
pp. 319-325
◽
Keyword(s):
Keyword(s):